[ Price : $8.95]
New studies by FDA drug promotion staff find that consumers conflated a drugs benefits and risks when they were exposed to both a ...[ Price : $8.95]
Ionis Pharmaceuticals reports favorable data from a Phase 1/2 open-label study of ION582 in people with Angelman syndrome.[ Price : $8.95]
FDA clears a Varian 510(k) for new functionality to its Ethos radiotherapy system for treating cancer.[ Price : $8.95]
FDA grants Tulavi Therapeutics a de novo marketing authorization for its Allay Nerve Cap, a surgical hydrogel designed to protect ...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Pediatric Inflammatory Bowel Disease: Developing Drugs for ...[ Price : $8.95]
Mainz Biomed files an application requesting a breakthrough device designation for what it calls its non-invasive next-generation ...[ Price : $8.95]
FDA announces an 11/6 public workshop entitled Accreditation Scheme for Conformity Assessment and Use of Chemical Analysis to Supp...